| Revenue growth | FY26 Net Sales grew 11.23% YoY to ₹502.55 Cr. |
|---|---|
| Margins | Higher raw material prices in Beverages; lower prices in OTC. |
| Demand visibility | Positive outlook with relaunch of Relief brand and new capacity. |
| Management confidence | Confident in demand environment and unique value propositions. |
Growth
FY26 Net Sales grew 11.23% to ₹502.55 Cr. FY26 PAT rose 13.95% to ₹57.92 Cr.
Outlook
New sanitary pad plant starting May 2026; target 100k chemists by Sept FY27; relaunching Relief brand.
Risks
COGS inflation due to Middle East wars affecting crude prices and supply chains; legal lease rent charge.
Earnings Call filed with BSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹506.35
- Market cap
- ₹1,464 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.1×Sector 50.4×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Investor Presentation: Key Takeaways
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
- Call
- Guides 10% growth
Amrutanjan Health Care Q1 FY27 Results: Net Profit ₹4.4 Cr, Down 47.0% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr · -47.0% YoY
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.
Amrutanjan Health Care Q4 FY26 Results: Net Profit ₹16.2 Cr, Up 6.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹149.8 Cr (+10.6% YoY) and net profit of ₹16.2 Cr (+6.6% YoY) for Q4 FY26.
- Key figure
- Net profit ₹16.2 Cr · +6.6% YoY